Company's stock falls 15% after it says its research-instrument business has been impacted Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after ...
As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their ...
8d
Assessing Becton Dickinson’s Valuation After Recent Share Weakness And Planned Business Separation
Becton Dickinson (BDX) has been under pressure, with the share price showing a 0.2% decline over the past day, about 4.6% ...
Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago. These ...
Aug 7 (Reuters) - Becton Dickinson (BDX.N), opens new tab raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for ...
Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding its ...
(Reuters) -Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down ...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against ...
6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...
Becton Dickinson was hit with a patent infringement lawsuit on Oct. 27 in New Jersey District Court over its PowerPort line of implantable vascular access devices. The action, brought by FisherBroyles ...
Hosted on MSN
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Becton Dickinson & Co.’s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results